Ezose, Hirosaki University Partner on Glycomics Research Targeting Prostate Cancer | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Ezose Sciences and Hirosaki University in Japan today announced a glycomics research collaboration to identify new biomarkers for the prediction and monitoring of progress of prostate cancer and other urological cancers.

Under the terms of the deal, Hirosaki researchers will collect urine samples from well-characterized patients and control populations in Japan, and Ezose will analyze the samples using its GlycanMap platform.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

BGI CEO Ye Yin says that mapping variation within the human genome will bring a "big data revolution" to healthcare, Wired UK writes.

All the images that investigators produce through their research present a challenge to share, Nature News reports.

The House of Representatives science committee has approved a measure that includes new rules for large National Science Foundation projects, ScienceInsider reports.

In PLOS this week: founder mutation linked to some leukoencephalopathy cases, transcript and protein profiles of the kissing bug, and more.